Vulvar lichen sclerosus. Immunohistologic evaluation before and after therapy

J Reprod Med. 1994 Feb;39(2):110-4.

Abstract

In 20 women with vulvar lichen sclerosus (LS) we analyzed the immunohistologic features of the dermal lymphoid infiltrate and the number of epidermal CD1a+ cells (Langerhans cells). Activated (HLA-Dr+) T cells, associated with CD1a+ accessory cells, were found in the dermis in all cases. The number of CD1a+ epidermal cells was increased, and the cells expressed strong HLA-DR+ staining. These findings suggest activation of the skin immune system in vulvar LS lesions. Conventional 2% testosterone therapy failed to modify the immunohistologic features. Clobetasol, 0.05%, application seemed more effective in down-regulating the skin's immune system activation profile.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal
  • Antigens, CD / analysis
  • Cell Adhesion Molecules / analysis
  • Child
  • Clobetasol / pharmacology
  • Clobetasol / therapeutic use
  • Epidermal Cells
  • Epidermis / drug effects
  • Epidermis / immunology
  • Female
  • HLA-DR Antigens / analysis
  • Humans
  • Langerhans Cells / drug effects
  • Langerhans Cells / pathology
  • Lichenoid Eruptions / drug therapy
  • Lichenoid Eruptions / immunology*
  • Lichenoid Eruptions / pathology
  • Middle Aged
  • Testosterone / pharmacology
  • Testosterone / therapeutic use
  • Vulvar Diseases / drug therapy
  • Vulvar Diseases / immunology*
  • Vulvar Diseases / pathology

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Cell Adhesion Molecules
  • HLA-DR Antigens
  • Testosterone
  • Clobetasol